Abstract: An improved patient monitoring system can include a processor device, a display, a first sensor in communication with the processor device, the first sensor being at least one of an electrocardiogram sensor, a pressure sensor, a blood oxygenation sensor, an image sensor, an impedance sensor, or a physiological sensor. The system can include a second sensor in communication with the processor device, the second sensor being a physiological sensor. The processor device can be configured to utilize the first accuracy, the second accuracy, the first correlation, the second correlation to determine a recommendation for fusing the first data model with the second data model.

Abstract: A high-density connecting device is provided. The high-density connecting device includes a first connecting module and a second connecting module. The first connecting module includes a first casing assembly, a first circuit board, and a first socket connector. The second connecting module includes a second casing assembly, a second circuit board, and a second socket connector. When the first connecting module is mated with the second connecting module, a junction end of the first circuit board and a junction end of the second circuit board are inserted into the first socket connector and the second socket connector, respectively, so that the junction end of the first circuit board and the junction end of the second circuit board are electrically connected to the first socket connector and the second socket connector, respectively.

Abstract: A high-density connecting device is provided. The high-density connecting device includes a first connecting module and a second connecting module. The first connecting module includes a first casing assembly, a first circuit board, and a first socket connector. The second connecting module includes a second casing assembly, a second circuit board, and a second socket connector. When the first connecting module is mated with the second connecting module, a junction end of the first circuit board and a junction end of the second circuit board are inserted into the first socket connector and the second socket connector, respectively, so that the junction end of the first circuit board and the junction end of the second circuit board are electrically connected to the first socket connector and the second socket connector, respectively.

Abstract: A connector with a direct locking and a rotational pre-ejection function is provided. The connector includes an insulated body, a plurality of terminals, an inner shell, an outer shell, a fastener, an ejector, a first elastic element, and a second elastic element. A plurality of push blocks are disposed in the outer shell, the ejector has a plurality of slope surfaces, and the push blocks are in contact with the slope surfaces, respectively. When the connector and a mating connector are inserted into each other, snap bodies of the fastener and fastener bodies of the mating connector can be snapped into each other to be directly locked. When the connector and the mating connector are to be separated from each other, the outer shell can be rotated to cause the snap bodies to disengage and to cause the push blocks to rotate while in contact with the sloped surfaces to effect ejector rods to move forwardly to eject the mating connector.

Abstract: The invention provides compositions and methods for treating breast cancer. Specifically, the invention relates to administering a Transforming Growth Factor beta (TGF?) antagonist in combination with capecitabine and ixabepilone to treat breast cancer.

Abstract: A buckle assembly includes a first buckle member having an insertion member, a second buckle member, a first buckle latch, a second buckle latch, a plurality of resilient elements, and a locking arrangement. The locking arrangement includes at least two locking protrusions and at least one guiding member. The locking protrusions are extended from one of the insertion member and the second buckle body, and are arranged to form a locking channel between the two locking protrusions. The guiding member is extended from the remaining one of the insertion member and the second buckle body, and is arranged to be inserted in the locking channel formed by the locking protrusions so as to retain the first buckle member to be locked with the second buckle member when the first buckle latch and the second buckle latch are in the locked position.

Abstract: A buckle assembly includes a first buckle member having an insertion member, a second buckle member, a first buckle latch, a second buckle latch, a plurality of resilient elements, and a locking arrangement. The locking arrangement includes at least two locking protrusions and at least one guiding member. The locking protrusions are extended from one of the insertion member and the second buckle body, and are arranged to form a locking channel between the two locking protrusions. The guiding member is extended from the remaining one of the insertion member and the second buckle body, and is arranged to be inserted in the locking channel formed by the locking protrusions so as to retain the first buckle member to be locked with the second buckle member when the first buckle latch and the second buckle latch are in the locked position.

Abstract: A buckle assembly includes a first buckle member, a second buckle member and a locking arrangement. The first buckle member includes a first buckle body and an insertion member. The second buckle member includes a second buckle body having a receiving slot, a first buckle latch and a second buckle latch pivotally connected to the second buckle body to move between a locked position and an unlocked position, and a plurality of resilient elements mounted in the second buckle body. The locking arrangement includes a first locking member extended from one of the first buckle member and the second buckle member to retain one of the first buckle latch and the second buckle latch at a locked position.

Abstract: The invention provides compositions and methods for treating breast cancer. Specifically, the invention relates to administering a Transforming Growth Factor beta (TGF?) antagonist in combination with capecitabine and ixabepilone to treat breast cancer.

Abstract: A buckle assembly includes a first buckle member, a second buckle member and a locking arrangement. The first buckle member includes a first buckle body and an insertion member. The second buckle member includes a second buckle body having a receiving slot, a first buckle latch and a second buckle latch pivotally connected to the second buckle body to move between a locked position and an unlocked position, and a plurality of resilient elements mounted in the second buckle body. The locking arrangement includes a first locking member extended from one of the first buckle member and the second buckle member to retain one of the first buckle latch and the second buckle latch at a locked position.

Abstract: Compositions and methods are provided herein for improved dual immunization strategies that induce in a subject a robust immune response. The methods described are therefore useful for treating and/or preventing (i.e., reducing the likelihood or risk of occurrence) different diseases, disorders, and conditions such as cancers and infectious diseases for which induction of a humoral immune response and/or cellular immune response is desired and beneficial.

Abstract: A buckle assembly includes a first buckle member, a second buckle member and a locking arrangement. The first buckle member includes a first buckle body and an insertion member. The second buckle member includes a second buckle body having a receiving slot, a first buckle latch and a second buckle latch pivotally connected to the second buckle body to move between a locked position and an unlocked position, and a plurality of resilient elements mounted in the second buckle body. The locking arrangement includes a first locking member extended from one of the first buckle member and the second buckle member to retain one of the first buckle latch and the second buckle latch at a locked position.

Abstract: The invention provides compositions and methods for treating breast cancer. Specifically, the invention relates to administering a Transforming Growth Factor beta (TGF?) antagonist in combination with capecitabine and ixabepilone to treat breast cancer.

Abstract: A buckle assembly includes a first buckle member, a second buckle member and a locking arrangement. The first buckle member includes a first buckle body and an insertion member. The second buckle member includes a second buckle body having a receiving slot, a first buckle latch and a second buckle latch pivotally connected to the second buckle body to move between a locked position and an unlocked position, and a plurality of resilient elements mounted in the second buckle body. The locking arrangement includes a first locking member extended from one of the first buckle member and the second buckle member to retain one of the first buckle latch and the second buckle latch at a locked position.

Abstract: The invention provides compositions and methods for treating breast cancer. Specifically, the invention relates to administering a Transforming Growth Factor beta (TGF?) antagonist in combination with capecitabine and ixabepilone to treat breast cancer.

Abstract: An aerodynamic vented rotor comprises an outboard disc, an inboard disc spaced from the outboard disc, and fins extending between the outboard disc and the inboard disc and defining vents therebetween. The fins have an airfoil-shaped cross section with a leading edge facing radially inwardly on the rotor. The fins constitute an inner core, and a hat section extends from the inner core of the rotor.

Abstract: A controllable capillary pump utilizing groupings of capillary tubes. Since individual capillary tubes produce different flow rates depending on their diameter, length and cross-sectional shape, it is possible to control the flow rate by providing different groups of capillary tubes. These groups may be included on a rotating cylinder so that a selection may be made merely by rotating the cylinder.

Abstract: A process for forming a dual damascene opening, in a composite layer comprised with low k layers, to accommodate a dual damascene type, copper structure, has been developed. The process features the use of a silicon oxide layer, formed on the surfaces of the composite layer, exposed in the narrow diameter, via hole component of the dual damascene opening. The silicon oxide layer prevents via poisoning, or outgassing of amines or hydroxyls from the low k layers exposed in the via hole opening, that can evolve during a subsequent photolithographic development cycle, used to define the trench shape component of the dual damascene opening. The protective silicon oxide layer is conformally formed on the exposed-surfaces of the via hole component, via a liquid phase deposition procedure, performed at room temperature.